Small-cell lung cancer is rarely cured with standard chemotherapy, despite initial good responses. The concept of high-dose induction therapy for extensive-stage patients has been explained in a series of pilot studies. The rationale of this approach and the most recent preliminary results will be presented.
|Original language||English (US)|
|Number of pages||3|
|Journal||Seminars in oncology|
|Issue number||3 SUPPL. 3|
|State||Published - Sep 1986|
ASJC Scopus subject areas